On December 31, 2025, healthcare technology firm Veradigm Inc. extended Interim Chief Financial Officer Leland Westerfield’s employment term through June 30, 2026, following prior extensions that had ...

The latest announcement is out from Veradigm ( (MDRX) ).

As of December 16, 2023, the average one-year price target for Veradigm is 17.34. The forecasts range from a low of 13.13 to a high of $27.30. The average price target represents an increase of 61.30% ...

Shares of MDRX stock opened at $9.05 on Thursday. Veradigm has a 1 year low of $5.01 and a 1 year high of $13.62. The firm’s fifty day simple moving average is $9.55 and its 200 day simple moving ...

Health tech company Veradigm (OTC:MDRX) has granted another term extension to its interim chief financial officer, Leland Westerfield, who took over its lead finance position in December 2023 ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 22, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of ...

Veradigm Inc (NASDAQ:MDRX) shares are trading lower after it provided below-consensus FY23 guidance. For FY23, the company expects revenue (on a GAAP basis) of $608 million-$622 million (vs. $637.67 ...

NEW YORK, NY / ACCESSWIRE / December 8, 2023 / If you suffered a loss on your Veradigm Inc. (NASDAQ:MDRX) investment and want to learn about a potential recovery under the federal securities laws, ...